Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
europe top stories
3
×
life sciences
national blog main
national top stories
novartis
3
×
san francisco top stories
biogen
boston blog main
boston top stories
cancer
europe blog main
fda
genentech
indiana blog main
indiana top stories
national
new york top stories
roche
san francisco blog main
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
avapritinib
billy dunn
bioeurope
biomarin pharmaceutical
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
capmatinib
cara therapeutics
clinical trials
deerfield management
What
fda
3
×
drug
medicines
new
therapy
activity
address
approval
approvals
approved
approves
atrophy
bio
biogen
blueprint
cancer
carries
certain
clamped
covid
daily
delays
designed
developing
economic
evrysdi
fast
friday
genetic
green
home
including
intended
ipo
isn’t
latest
lights
liquid
lot
medicine
Language
unset
3
×
Current search:
fda
×
biotech
×
unset
×
novartis
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More